Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.

Oyama, Y; Barr, W G; Statkute, L; Corbridge, T; Gonda, E A; Jovanovic, B; Testori, A; Burt, R K

Oyama, Y; Barr, W G; Statkute, L; Corbridge, T; Gonda, E A; Jovanovic, B; Testori, A; Burt, R K.

Affiliation

Oyama Y; Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Bone Marrow Transplant ; 40(6): 549-55, 2007 Sep.

Article in En | MEDLINE | ID: mdl-17646844

Subject(s)

Hematopoietic Stem Cell Transplantation; Scleroderma, Systemic/therapy; Transplantation Conditioning/adverse effects; Transplantation Conditioning/methods; Adult; Blood Sedimentation; Child; Erythrocyte Transfusion; Female; Follow-Up Studies; Humans; Kidney Function Tests; Male; Middle Aged; Platelet Transfusion; Prognosis; Pulmonary Wedge Pressure; Respiratory Function Tests; Skin; Stroke Volume; Survival Rate; Transplantation, Autologous; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2007 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links